Interestingly, even in the absence of cisplatin, the DU145 prostate cancer cell line, which was refractory to the anti-cancer activities of BIN1 and TP53 when transfected individually, became vulnerable to ectopically expressed TP53 in the DU145 cells retrovirally expressing BIN1 (Figure S1). Here, BIN1 is linked to prostate cancer.